Finance

Beta
Lists
XENE:NASDAQ
Xenon Pharmaceuticals Inc
$51.73
-2.38%
(-1.26) 1D
$51.57
-0.31% (-0.16)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XENE...
Open
$53.14
High
$53.61
Low
$51.52
Mkt. cap
5.00B
Avg. vol.
1.18M
Volume
1.69M
52-wk high
$63.95
52-wk low
$30.00
EPS
-$4.70
Beta
0.62
Shares outstanding
96.67M
No. of employees
364
Open
$53.14
High
$53.61
Low
$51.52
Mkt. cap
5.00B
Avg. vol.
1.18M
Volume
1.69M
52-wk high
$63.95
52-wk low
$30.00
EPS
-$4.70
Beta
0.62
Shares outstanding
96.67M
No. of employees
364
Analyst outlook
Analyst Ratings
Based on 17 analysts giving stock ratings to XENE in the past 3 months
Strong Buy
Buy
17
Hold
0
Sell
0
12 month forecast
Based on 17 Wall Street analysts offering 12 month price targets for XENE in the last 3 months.
Highest
Current $51.73
$100.00 (+93.31%)
Average
$81.10 (+56.78%)
Lowest
$63.00 (+21.79%)
News stories
From sources across the web
About Xenon Pharmaceuticals Inc
CEO-
Employees364
Founded1996
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitexenon-pharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
74.98M
77.05M
87.70M
88.51M
Cost of revenue
74.98M
77.05M
87.70M
88.51M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.24M
19.28M
22.07M
23.82M
Operating expense
19.24M
19.28M
22.07M
23.82M
Total operating expenses
94.23M
96.34M
109.77M
112.33M
Operating income
-94.23M
-96.34M
-109.77M
-112.33M
Other non operating income
-
-
-
-
EBT including unusual items
-85.33M
-90.22M
-104.72M
-104.87M
EBT excluding unusual items
-85.33M
-90.22M
-104.72M
-104.87M
Income tax expense
-626.00K
677.00K
538.00K
-2.57M
Effective tax rate
0.73%
-0.75%
-0.51%
2.45%
Other operating expenses
-
-
-
-
Net income
-84.71M
-90.90M
-105.26M
-102.30M
Net profit margin
-
-
-
-
Earnings per share
-1.07
-1.15
-1.31
-1.17
Interest and investment income
7.20M
6.21M
5.34M
6.91M
Interest expense
-
-
-
-
Net interest expenses
7.20M
6.21M
5.34M
6.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
-93.60M
-95.70M
-109.16M
-111.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer